Handa Pharmaceuticals, Inc.
Informe acción TPEX:6620
Capitalización de mercado: NT$8.6b
Salud financiera de hoja de balance de Handa Pharmaceuticals
Salud financiera controles de criterios 6/6 Handa Pharmaceuticals tiene un patrimonio de accionistas total de NT$2.9B y una deuda total de NT$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son NT$3.1B y NT$244.7M respectivamente. El BAIT de Handa Pharmaceuticals es de NT$525.4M, por lo que su ratio de cobertura de intereses es de -11.5. Tiene efectivo e inversiones a corto plazo que ascienden a NT$2.5B.
Información clave Ratio de cobertura de intereses -11.5x Efectivo NT$2.53b Patrimonio NT$2.90b Total pasivo NT$244.70m Activos totales NT$3.15b
Actualizaciones recientes sobre salud financiera
Mostrar todas las actualizaciones
New minor risk - Dividend sustainability Oct 25
Second quarter 2024 earnings released: EPS: NT$0.73 (vs NT$1.90 in 2Q 2023) Aug 17
Investor sentiment deteriorates as stock falls 15% Jul 29
Investor sentiment deteriorates as stock falls 17% May 30
First quarter 2024 earnings released: EPS: NT$0.83 (vs NT$1.90 in 1Q 2023) May 19
Investor sentiment improves as stock rises 16% May 13
New minor risk - Share price stability Apr 20
Investor sentiment deteriorates as stock falls 15% Apr 17
Handa Pharmaceuticals, Inc., Annual General Meeting, Jun 20, 2024 Apr 03
Full year 2023 earnings released: EPS: NT$5.41 (vs NT$0.32 loss in FY 2022) Apr 03
New minor risk - Share price stability Jan 30
Third quarter 2023 earnings released: EPS: NT$1.07 (vs NT$0.18 in 3Q 2022) Dec 28
New minor risk - Share price stability Nov 17
New minor risk - Shareholder dilution Sep 10
Full year 2022 earnings released: NT$0.32 loss per share (vs NT$2.10 loss in FY 2021) Apr 22
Less than half of directors are independent Nov 16
First half 2022 earnings released: NT$0.71 loss per share (vs NT$1.01 loss in 1H 2021) Aug 17
Full year 2021 earnings released: NT$2.10 loss per share (vs NT$2.44 loss in FY 2020) Apr 30
Less than half of directors are independent Apr 27
First half 2021 earnings released: NT$1.01 loss per share (vs NT$1.26 loss in 1H 2020) Aug 18
Handa Pharmaceuticals, Inc., Annual General Meeting, Jun 08, 2021 Mar 20
New 90-day high: NT$30.70 Feb 25
Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years. Feb 24
New 90-day high: NT$28.15 Jan 04
We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth Dec 29
New 90-day high: NT$27.15 Nov 07
New 90-day low: NT$22.05 Sep 24
First half earnings released Aug 13
New 90-day low - NT$26.95 Aug 06
Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (NT$2.8B) de 6620 superan a sus pasivos a corto plazo (NT$156.0M).
Pasivo a largo plazo: Los activos a corto plazo de 6620 (NT$2.8B) superan a sus pasivos a largo plazo (NT$88.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 6620 está libre de deudas.
Reducción de la deuda: 6620 no tenía deudas hace 5 años.
Cobertura de la deuda: 6620 no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo .
Cobertura de intereses: 6620 no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.
Descubre empresas con salud financiera Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}